The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. With its broad range of academic disciplines and internationally recognised research communities, UiO is an important contributor to society.

Centre for Molecular Medicine Norway (NCMM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway. From 2017 NCMM is merged with the Biotechnology Centre of Oslo and now has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.

PhD Research Fellowship: Cancer Drug Sensitivity Screening

Denne stillingen er ikke aktiv.

Om stillingen

  • Søknadsfrist
    Avsluttet
  • Arbeidsgiver
    University of Oslo
  • Nettside
  • Kommune
    Oslo
  • Jobbnorge-ID
    143596
  • Intern-ID
    2017/12178
  • Omfang
    Heltid
  • Varighet
    Engasjement

Se mer

Finn andre stillinger